Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Michelle S. Miller, Oleg Schmidt-Kittler, David M. Bolduc, Evan T. Brower, Daniele Chaves-Moreira, Marc Allaire, Kenneth W. Kinzler, Ian G. Jennings, Philip E. Thompson, Philip A. Cole, L. Mario Amzel, Bert Vogelstein, Sandra B. Gabelli
Published Jul 25, 2014 · Vol. 5, No. 14 · pp. 5198-5208
Abhijit A. Patil, Parag Sayal, Marie-Lise Depondt, Ryan D. Beveridge, Anthony Roylance, Deepti H. Kriplani, Katie N. Myers, Angela Cox, David Jellinek, Malee Fernando, Thomas A. Carroll, Spencer J. Collis
Published Jul 16, 2014 · Vol. 5, No. 15 · pp. 6414-6424
Martin Neumann, Sebastian Vosberg, Cornelia Schlee, Sandra Heesch, Stefan Schwartz, Nicola Gökbuget, Dieter Hoelzer, Alexander Graf, Stefan Krebs, Isabelle Bartram, Helmut Blum, Monika Brüggemann, Jochen Hecht, Stefan K. Bohlander, Philipp A. Greif, Claudia D. Baldus
Published Jul 15, 2014 · Vol. 6, No. 5 · pp. 2754-2766